Patient Based Evidence: Using patient preference research for PBAC/MSAC
07 August 2020
Webinars for patient groups and communities wanting to know about patient preference research for reimbursement decisions in Australia
The Patient Voice Initiative invites patient groups and communities to join us for this three-part webinar series on patient-based evidence. In this webinar, we’ll focus on answering your questions about patient preference studies.
- Data that makes a difference and what patient-based evidence can add (Jo Watson, PBAC Deputy Chair)
- What is patient preference research and what can it do? (Dr Simon Fifer, CaPPRe and PVI)
- How and why Myeloma Australia uses patient preference research (Steve Roach, CEO, Myeloma Australia & Nella Combe, Nurse, Myeloma Australia)
- Time for your questions
This webinar is provided for free, thanks to the following sponsorship of the Patient Voice Initiative:
Gold Sponsors: Bristol-Myers Squibb; Lilly; Sanofi
Silver Sponsors: Astra Zeneca; Biogen; Janssen; MSD; Pfizer; Medicines Australia; Shire/Takeda
Ongoing inkind support: CaPPRe; Rare Cancers Australia
And the generosity of all speakers who have given their time for free.